Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jacot

Showing results (51-60 of 212) with videos related to

Pageof 22
Sort By:
Bulletin Du Cancer|May 23, 2002
[Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination]David Azria, William Jacot, Patricia Prost, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancerJean-Louis Pujol, Xavier Quantin, William Jacot, et al.
Bulletin Du Cancer|September 13, 2011
[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications]William Jacot, Stéphane Pouderoux, Frédéric Bibeau, et al.
Breast Cancer Research and Treatment|May 8, 2012
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapyWilliam Jacot, Stéphane Pouderoux, Simon Thezenas, et al.
BMC Cancer|June 8, 2010
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective studyWilliam Jacot, Marie-Cécile Gerlotto-Borne, Simon Thezenas, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2011
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patientsWilliam Jacot, Jean-Louis Pujol, Mohammad Chakra, et al.
Frontiers in Immunology|August 18, 2023
NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cellsMauricio Campos-Mora, William Jacot, Genevieve Garcin, et al.
Breast (Edinburgh, Scotland)|March 3, 2026
Real-world treatment patterns and outcomes in HER2-low, HR+ metastatic breast cancer patients previously treated with endocrine therapy in the United StatesShanu Modi, Danalyn Byng, Suyuan Zhang, et al.
Clinical Chemistry|August 6, 2021
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung CancerLéa Sinoquet, William Jacot, Ludovic Gauthier, et al.
Cancer Informatics|May 21, 2009
Comparison of supervised classification methods for protein profiling in cancer diagnosisNadège Dossat, Alain Mangé, Jérôme Solassol, et al.
Pageof 22

Showing results (51-60 of 212) with videos related to

Sort By:
Pageof 22
Bulletin Du Cancer|May 23, 2002
[Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination]David Azria, William Jacot, Patricia Prost, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancerJean-Louis Pujol, Xavier Quantin, William Jacot, et al.
Bulletin Du Cancer|September 13, 2011
[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications]William Jacot, Stéphane Pouderoux, Frédéric Bibeau, et al.
Breast Cancer Research and Treatment|May 8, 2012
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapyWilliam Jacot, Stéphane Pouderoux, Simon Thezenas, et al.
BMC Cancer|June 8, 2010
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective studyWilliam Jacot, Marie-Cécile Gerlotto-Borne, Simon Thezenas, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2011
Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patientsWilliam Jacot, Jean-Louis Pujol, Mohammad Chakra, et al.
Frontiers in Immunology|August 18, 2023
NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cellsMauricio Campos-Mora, William Jacot, Genevieve Garcin, et al.
Breast (Edinburgh, Scotland)|March 3, 2026
Real-world treatment patterns and outcomes in HER2-low, HR+ metastatic breast cancer patients previously treated with endocrine therapy in the United StatesShanu Modi, Danalyn Byng, Suyuan Zhang, et al.
Clinical Chemistry|August 6, 2021
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung CancerLéa Sinoquet, William Jacot, Ludovic Gauthier, et al.
Cancer Informatics|May 21, 2009
Comparison of supervised classification methods for protein profiling in cancer diagnosisNadège Dossat, Alain Mangé, Jérôme Solassol, et al.
Pageof 22